Episode Details

Back to Episodes
011226 - Biosimilar Strategy Leads to Major Rx Savings - Andy Hetzel

011226 - Biosimilar Strategy Leads to Major Rx Savings - Andy Hetzel

Episode 1226 Published 1 month, 3 weeks ago
Description
January 12, 2026 ~ Lucy Ann Lance is joined by Andy Hetzel with Blue Cross Blue Shield of Michigan for A Healthier Michigan! Andy discusses the rising cost of health insurance premiums. He explains that unregulated drug prices, with nearly half of top prescribed drugs costing over $1,000 per month, are driving a 15% increase in drug claims. Blue Cross is addressing this by promoting lower-priced biosimilar drugs, such as one introduced last year that is 90% less expensive, saving customers millions. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us